Dean McGee Eye Institute has partnered with OU Health to become one of 17 centers in the US to offer a new treatment, Luxturna, to reverse vision loss in patients.
The researchers focused on coverage trends across an array of disease states, including lymphoma, vision loss, and spinal muscular atrophy, finding discrepancies in coverage across 16 states and Medicaid Care Organizations.
This article will discuss some of the most promising gene therapies for age-related macular degeneration, including ADVM-022, RGX-314, GT-005, and HMR59.
While not every form of blindness can be cured, recent scientific breakthroughs have uncovered new ways to treat some forms of inherited blindness through gene therapy.
Even on a clear night, the sky used to be almost totally dark for Adelaide teenager Orlando Lupoi but when he looked up a few months ago, he realised his life had changed.